Author response: Mortality in patients with psychogenic nonepileptic seizures
TerenceO'Brien, Neurologist, Monash University
Submitted July 29, 2020
We thank Dr. Sethi for his interest in our article1 and comment. We certainly agree that this group of patients should be evaluated and monitored for cardiovascular, cerebrovascular, or neoplastic disorder. 30.9% of the deaths in our cohort of psychogenic nonepileptic seizures (PNES) patients was due to one of these causes. Patients with PNES are over-represented in lower socioeconomic groups and have high incidence of modifiable risk factors for these disorders, such as smoking, alcohol and drug use, obesity, diabetes, and metabolic syndrome.
Disclosure
The author reports no relevant disclosures. Contact journal@neurology.org for full disclosures.
Reference
Nightscales R, McCartney L, Auvrez C, et al. Mortality in patients with psychogenic nonepileptic seizures. Neurology 2002 Epub July 20.
We thank Dr. Sethi for his interest in our article1 and comment. We certainly agree that this group of patients should be evaluated and monitored for cardiovascular, cerebrovascular, or neoplastic disorder. 30.9% of the deaths in our cohort of psychogenic nonepileptic seizures (PNES) patients was due to one of these causes. Patients with PNES are over-represented in lower socioeconomic groups and have high incidence of modifiable risk factors for these disorders, such as smoking, alcohol and drug use, obesity, diabetes, and metabolic syndrome.
Disclosure
The author reports no relevant disclosures. Contact journal@neurology.org for full disclosures.
Reference